Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension


This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age

Full Title of Study: “A Randomized, Double-blind, Placebo-controlled Factorial Study Evaluating the Efficacy and Safety of Co-administration of Olmesartan Medoxomil Plus Amlodipine Compared to Monotherapy in Patients With Mild to Severe Hypertension”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double


  • Drug: Olmesartan medoxomil
  • Drug: Amlodipine

Clinical Trial Outcome Measures

Primary Measures

  • Change from baseline in trough seated systolic blood pressure and seated diastolic blood pressure for each treatment arm

Secondary Measures

  • To evaluate the number (%) of patients achieving BP goal.
  • To characterize the pharmacokinetic interactions and the corresponding pharmacodynamic (BP) correlation

Participating in This Clinical Trial

Inclusion Criteria

  • Male or female patients – 18 years of age or older (20% equal to or older than 65 years) – With mild to severe hypertension defined as seated diastolic blood pressure of 95-120 mmHg while off any hypertensive medication Exclusion Criteria:

  • Patients should not have serious concomitant conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patients

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Daiichi Sankyo, Inc.
  • Provider of Information About this Clinical Study
    • Reinilde Heyrman, Daiichi Sankyo

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.